Postpartum Depression: Recognize, Understand, Help
The arrival of a baby is a joyful, yet simultaneously very responsible event in a woman's life. However, for many mothers, this period is overshadowed by the development of postpartum depression (PPD), which is a common and serious public health issue [1]. It is important to understand that PPD is not just the "baby blues" or temporary sadness, but a clinical condition that requires attention and treatment.
What is postpartum depression?
Postpartum depression is a form of depressive disorder that develops in women after childbirth. It can manifest within the first 12 months after the baby's birth [2]. Unlike the short-term "baby blues," which affects up to 80% of new mothers and usually resolves on its own within two weeks, PPD is characterized by more pronounced and persistent symptoms that significantly impact a woman's quality of life and her ability to care for herself and her child.
PPD is classified as a specific type of unipolar depression [7]. Its timely identification and treatment are critical, as it can negatively affect the child's development, family relationships, and the mother's overall well-being.
Signs and symptoms of postpartum depression
Symptoms of postpartum depression can vary, but often include:
- Persistent feelings of sadness, hopelessness, or emptiness.
- Severe fatigue, lack of energy, not related to sleep deprivation.
- Loss of interest in activities that previously brought pleasure.
- Sleep difficulties (insomnia or excessive sleepiness).
- Changes in appetite (loss or increase).
- Feelings of guilt, shame, or worthlessness.
- Irritability, anxiety, or panic attacks.
- Problems with concentration, memory, or decision-making.
- Thoughts of harming yourself or the baby (requires immediate help!).
- Detachment from the baby, partner, or friends.
It is important to remember that many of these symptoms can be dismissed as the normal fatigue of a new mother. However, if they persist for more than two weeks and interfere with normal life, it is necessary to seek help.
Risk factors: who is at increased risk?
Some women are more susceptible to developing postpartum depression. The main risk factors include:
- Anxiety during pregnancy. High levels of anxiety during the gestation period are a strong predictor of postpartum mental disorders, including depression and generalized anxiety disorder [3].
- Multiple Sclerosis (MS). A study conducted in Denmark showed that mothers with multiple sclerosis have an increased risk of developing PPD requiring antidepressant treatment compared to women without MS [2].
- Infertility and perinatal loss. Women who have faced infertility or pregnancy loss are at an increased risk of developing depression, anxiety, and post-traumatic stress disorder [6].
- Pre-existing mental health conditions. A history of trauma, as well as pre-existing mental disorders (e.g., depression or anxiety disorders), significantly increases the risk [6].
- Lack of social support. A lack of support from loved ones or social isolation is also a risk factor [6].
- Use of antidepressants before conception. Previous use of antidepressants may indicate a predisposition to depressive states [2].
Effective methods of support and treatment
Fortunately, postpartum depression is highly treatable. Modern approaches include both psychological and pharmacological methods.
Psychological interventions
Psychological methods are the first-line therapy for perinatal depression [1]. A meta-analysis of 43 studies involving 6,270 people showed that psychological interventions are effective in treating perinatal depression, and their effect persists for at least 6-12 months. They also positively influence social support, anxiety levels, and functional impairment [1].
Special attention is given to cognitive-behavioral therapy (CBT), which has proven its effectiveness. For example, the "Happy Mom – Healthy Baby" program, based on CBT and delivered by non-specialists during pregnancy, has shown effectiveness in preventing postpartum mental disorders, such as depression and generalized anxiety disorder, in women with moderate anxiety [3].
Pharmacotherapy
In cases of moderate to severe depression, or when psychotherapy is ineffective, antidepressants may be prescribed. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are common options [4].
The use of antidepressants during pregnancy and breastfeeding requires a careful assessment of the benefit-risk ratio. In one case, a woman with severe post-traumatic stress disorder and psychotic depression, for whom milnacipran (an antidepressant) led to significant improvement before pregnancy, faced a recurrence of symptoms after discontinuing it during pregnancy. After re-initiating milnacipran, taking into account risk assessment and shared decision-making, her condition improved [5]. This case highlights the complexity of decision-making and the need for an individualized approach.
Prevention and early detection
Early detection and prevention play a key role. Screening for depression and anxiety during pregnancy, as well as after childbirth, allows for timely assistance. For women with infertility or perinatal loss, psychoeducation, the provision of resources, and the opportunity to discuss their experiences and plans for future pregnancies are important [6].
When to seek help?
Do not hesitate to seek help if you or a loved one are experiencing symptoms of postpartum depression. The sooner treatment is started, the more effective it will be. Contact an obstetrician-gynecologist, general practitioner, psychologist, or psychiatrist. Your well-being is important not only for you but also for your baby and your entire family.
Sources
- Psychological treatment of perinatal depression: a meta-analysis. (Psychological medicine, 2023)
- Postpartum depression requiring treatment in mothers with multiple sclerosis: a nationwide cohort study. (Multiple sclerosis (Houndmills, Basingstoke, England), 2026)
- Anxiety-focused cognitive behavioral therapy delivered by non-specialists to prevent postpartum depression: a phase 3 randomized trial. (Nature medicine, 2024)
- Advances in research on the pathogenesis and clinical interventions for post-stroke depression. (Frontiers in neurology, 2026)
- Continuation of milnacipran during pregnancy in a patient with severe post-traumatic stress disorder and psychotic depression: a case report with 3-year pediatric follow-up. (Frontiers in psychiatry, 2026)
- Infertility and perinatal loss: when the bough breaks. (Current psychiatry reports, 2016)
- Subtyping depression: implications for treatment. (The Journal of clinical psychiatry, 1998)
The information provided in this article is for reference purposes only and cannot replace professional medical advice. Always consult a qualified specialist for diagnosis and treatment.